Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1132) 1132
Patent (20) 20
Book Chapter (19) 19
Conference Proceeding (10) 10
Book Review (5) 5
Book / eBook (3) 3
Newspaper Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (579) 579
male (504) 504
science & technology (491) 491
life sciences & biomedicine (485) 485
female (389) 389
psychiatry (383) 383
biological and medical sciences (364) 364
adult (350) 350
medical sciences (349) 349
schizophrenia (307) 307
psychology. psychoanalysis. psychiatry (303) 303
neurosciences & neurology (232) 232
schizophrenia - drug therapy (227) 227
neurosciences (215) 215
pharmacology. drug treatments (199) 199
middle aged (196) 196
animals (187) 187
psychopathology. psychiatry (186) 186
pharmacology & pharmacy (182) 182
neuropharmacology (176) 176
psychopharmacology (170) 170
antipsychotic agents - therapeutic use (164) 164
adult and adolescent clinical studies (145) 145
rats (141) 141
psycholeptics: tranquillizer, neuroleptic (131) 131
clozapine (120) 120
abridged index medicus (111) 111
schizophrenic psychology (102) 102
antipsychotic agents - adverse effects (101) 101
dopamine (101) 101
clozapine - therapeutic use (97) 97
psychoses (92) 92
antipsychotic agents - pharmacology (90) 90
psychiatric status rating scales (88) 88
schizophrenia - genetics (79) 79
treatment outcome (78) 78
adolescent (77) 77
serotonin (75) 75
dose-response relationship, drug (70) 70
dopamine - metabolism (62) 62
prolactin - blood (60) 60
aged (59) 59
clinical neurology (59) 59
antipsychotic drugs (58) 58
time factors (57) 57
depression (56) 56
clozapine - pharmacology (54) 54
schizophrenia - diagnosis (54) 54
rats, sprague-dawley (53) 53
receptors, serotonin - drug effects (49) 49
hydrocortisone - blood (48) 48
microdialysis (48) 48
pharmacogenetics (48) 48
genotype (47) 47
schizophrenia - blood (45) 45
clozapine - adverse effects (44) 44
phencyclidine (43) 43
psychology (42) 42
analysis of variance (41) 41
cognition (41) 41
psychotic disorders - drug therapy (41) 41
schizophrenia - physiopathology (41) 41
social sciences (41) 41
depressive disorder - blood (39) 39
drug therapy (39) 39
mood disorders (39) 39
5-ht (38) 38
prefrontal cortex - metabolism (38) 38
risk factors (38) 38
serotonin antagonists - pharmacology (37) 37
prolactin (36) 36
rats, inbred strains (36) 36
double-blind method (35) 35
mental disorders (35) 35
piperazines - pharmacology (35) 35
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (35) 35
receptors, serotonin - metabolism (35) 35
antipsychotics (34) 34
haloperidol - pharmacology (34) 34
creatine kinase - blood (33) 33
kinetics (33) 33
olanzapine (33) 33
techniques and methods (33) 33
analysis (32) 32
haloperidol (32) 32
prefrontal cortex - drug effects (32) 32
blood platelets - metabolism (31) 31
nucleus accumbens - metabolism (31) 31
suicide (31) 31
young adult (31) 31
antipsychotic agents - administration & dosage (30) 30
neuroleptics (30) 30
tardive dyskinesia (30) 30
depressive disorder - diagnosis (29) 29
genetics (29) 29
miscellaneous (29) 29
depressive disorder - drug therapy (28) 28
nucleus accumbens - drug effects (28) 28
sex factors (28) 28
weight gain - drug effects (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1183) 1183
French (8) 8
Portuguese (6) 6
Japanese (4) 4
German (3) 3
Korean (3) 3
Chinese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Perospirone: A Viewpoint by Herbert Y. Meltzer
by Meltzer H.Y
CNS drugs, ISSN 1172-7047, 2001, Volume 15, Issue 4, pp. 338 - 338
Perospirone, general | New drug profiles | Schizophrenia, treatment | Research and development | Antipsychotics, general | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Update on Typical and Atypical Antipsychotic Drugs
by Meltzer, Herbert Y
Annual review of medicine, ISSN 0066-4219, 1/2013, Volume 64, Issue 1, pp. 393 - 406
cognition | clozapine | extrapyramidal | antipsychotic | schizophrenia | psychosis | metabolic | Antipsychotic Agents - classification | Psychotic Disorders - physiopathology | Antipsychotic Agents - therapeutic use | Humans | Treatment Outcome | Psychotic Disorders - drug therapy | Cognition - drug effects | Physiological aspects | Antipsychotic drugs | Neural circuitry | Health aspects | Psychotropic drugs | Schizophrenia | Mental health care | Side effects | Psychopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Ziprasidone
: A Viewpoint by Herbert Y. Meltzer
by Meltzer, Herbert Y
CNS drugs, ISSN 1172-7047, 8/1997, Volume 8, Issue 2, pp. 161 - 161
Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. New trends in the treatment of schizophrenia
by Meltzer, Herbert Y
CNS & neurological disorders drug targets, ISSN 1871-5273, 10/2017, Volume 16, Issue 8, pp. 900 - 906
Psychosis | Atypical antipsychotics | Pharmacogenetics | Dopamine | GABA | Acetylcholine | Cognition | Glutamate | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Schizophrenia - metabolism | Schizophrenia - genetics | Antipsychotic Agents - therapeutic use | Cognition Disorders - etiology | Humans | Neurotransmitter Agents - metabolism | Schizophrenia - complications | Disease Management | Schizophrenia - drug therapy
Journal Article
Details down arrow
5. The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia
by Rajagopal, Lakshmi and Massey, Bill W and Huang, Mei and Oyamada, Yoshihiro and Meltzer, Herbert Y
Current pharmaceutical design, ISSN 1381-6128, 2014, Volume 20, Issue 31, pp. 5104 - 5114
NOR | 5-HT7 | 5-HT1A | Schizophrenia | Cognition | Lurasidone | Declarative memory | PCP | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Receptors, N-Methyl-D-Aspartate - drug effects | Cognition Disorders - chemically induced | Humans | Schizophrenia - complications | Acetylcholine - metabolism | Excitatory Amino Acid Agonists - pharmacology | Cognition Disorders - drug therapy | Schizophrenic Psychology | Serotonin Antagonists - pharmacology | Brain - drug effects | Brain - metabolism | Cognition Disorders - complications | Animals | Recognition (Psychology) - drug effects | Antipsychotic Agents - therapeutic use | GABA Agonists - pharmacology | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Dopamine - metabolism | Nicotinic Agonists - pharmacology | Disease Models, Animal
Journal Article
Details down arrow
6. Clozapine: Balancing safety with superior antipsychotic efficacy
by Meltzer, Herbert Y
Clinical schizophrenia & related psychoses, ISSN 1935-1232, 10/2012, Volume 6, Issue 3, pp. 134 - 144
Myocarditis | Metabolic side effects | Agranulocytosis | Schizophrenia | Treatment resistant | Clozapine | Suicide | Myocarditis - chemically induced | Agranulocytosis - chemically induced | Antipsychotic Agents - adverse effects | Clozapine - administration & dosage | Humans | Risk Factors | Metabolic Diseases - epidemiology | Metabolic Diseases - chemically induced | Schizophrenia - epidemiology | Agranulocytosis - epidemiology | Antipsychotic Agents - administration & dosage | Myocarditis - epidemiology | Schizophrenia - drug therapy | Clozapine - adverse effects
Journal Article
Details down arrow
7. Full Text Lorcaserin and pimavanserin: Emerging selectivity of serotonin receptor subtype-targeted drugs
by Meltzer, Herbert Y and Roth, Bryan L
The Journal of clinical investigation, ISSN 0021-9738, 12/2013, Volume 123, Issue 12, pp. 4986 - 4991
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Serotonin - physiology | Serotonin 5-HT2 Receptor Agonists - therapeutic use | Obesity - drug therapy | Benzazepines - adverse effects | Humans | Receptors, Serotonin - drug effects | Serotonin 5-HT2 Receptor Agonists - adverse effects | Serotonin 5-HT2 Receptor Agonists - pharmacology | Parkinson Disease - drug therapy | Piperidines - pharmacology | Urea - analogs & derivatives | Diabetes Mellitus, Type 2 - therapy | Heart Valve Diseases - chemically induced | Molecular Structure | Serotonin 5-HT2 Receptor Antagonists - adverse effects | Benzazepines - pharmacology | Parkinson Disease - psychology | Serotonin 5-HT2 Receptor Antagonists - pharmacology | Serotonin 5-HT2 Receptor Antagonists - therapeutic use | Urea - therapeutic use | Benzazepines - therapeutic use | Piperidines - therapeutic use | Piperidines - adverse effects | Urea - adverse effects | Schizophrenia - drug therapy | Diabetes Mellitus, Type 2 - drug therapy | Urea - pharmacology | Serotonin agonists | Obesity | Receptors | Parkinson's disease | Serotonin | Lorcaserin | Dosage and administration | Cellular signal transduction | Research | Properties | Drug therapy | Psychotropic drugs | Proteins | Heart | Lysergic acid diethylamide--LSD | Bias | Cloning | Technological change | Cardiovascular disease | Smooth muscle | Drug dosages | Index Medicus | Abridged Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Association of a functional polymorphism in neuropeptide y with antipsychotic-induced weight gain in schizophrenia patients
by Tiwari, Arun K and Brandl, Eva J and Weber, Caroline and Likhodi, Olga and Zai, Clement C and Hahn, Margaret K and Lieberman, Jeffrey A and Meltzer, Herbert Y and Kennedy, James L and Müller, Daniel J
Journal of clinical psychopharmacology, ISSN 0271-0749, 02/2013, Volume 33, Issue 1, pp. 11 - 17
rs16147 | association | clozapine | NPY | weight gain | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psycholeptics: tranquillizer, neuroleptic | Psychology. Psychoanalysis. Psychiatry | Psychoses | Adult and adolescent clinical studies | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Schizophrenia | Biological and medical sciences | Medical sciences | Neuropharmacology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Neuropeptide Y - genetics | Young Adult | Adult | Female | Weight Gain - drug effects | Ohio - epidemiology | European Continental Ancestry Group - genetics | Risk Assessment | Gene Frequency | Risk Factors | African Americans - genetics | Genotype | Chi-Square Distribution | Germany - epidemiology | Phenotype | Schizophrenia - ethnology | Receptor, Cannabinoid, CB1 - genetics | Analysis of Variance | Weight Gain - genetics | Benzodiazepines - adverse effects | Polymorphism, Single Nucleotide | Schizophrenia - drug therapy | Clozapine - adverse effects | New York - epidemiology | Index Medicus | Neuropeptide Y | Obesity | Neuroleptics | Mental disorders | Genetic diversity | Clozapine | Haloperidol | Body weight gain | Gene polymorphism | olanzapine | Side effects | Food intake | Cannabinoid receptors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems
by Meltzer, Herbert Y and Huang, Mei
2008, ISBN 0444532358, Volume 172
haloperidol | serotonin | microdialysis | clozapine | antipsychotic | schizophrenia | dopamine | Brain - anatomy & histology | Receptors, Dopamine - metabolism | Humans | Hallucinogens - metabolism | Serotonin Antagonists - therapeutic use | Treatment Outcome | Clinical Trials as Topic | Neuroprotective Agents - metabolism | Receptors, Serotonin - metabolism | Brain - metabolism | Prolactin - metabolism | Animals | Protein Isoforms - metabolism | Antipsychotic Agents - therapeutic use | Neuronal Plasticity | Serotonin - metabolism | Antipsychotic Agents - metabolism | Serotonin Antagonists - metabolism | Schizophrenia - drug therapy | Dopamine - metabolism | Index Medicus
Book Chapter
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
by Meltzer, Herbert Y and Sumiyoshi, Tomiki
Behavioural brain research, ISSN 0166-4328, 12/2008, Volume 195, Issue 1, pp. 98 - 102
5-HT1A | Schizophrenia | Cognition | Dopamine | Serotonin | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Behavioral Sciences | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Attention Must Be Paid: The Association of Plasma Clozapine/NDMC Ratio With Working Memory
by Meltzer, Herbert Y
The American journal of psychiatry, ISSN 0002-953X, 06/2015, Volume 172, Issue 6, pp. 502 - 504
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Schizophrenia - blood | Humans | Psychotic Disorders - psychology | Female | Male | Memory, Short-Term - drug effects | Clozapine - analogs & derivatives | Psychotic Disorders - blood | Schizophrenia - drug therapy | Clozapine - pharmacokinetics | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
by Meltzer, Herbert Y and Horiguchi, Masakuni and Massey, Bill W
Psychopharmacology, ISSN 0033-3158, 2/2011, Volume 213, Issue 2, pp. 289 - 305
Neurosciences | Dopamine | Serotonin | Schizophrenia | Cognition | Glutamate | Biomedicine | Phencyclidine | NMDA | 5-HT 2A | Novel object recognition | Pharmacology/Toxicology | Psychiatry | 5-HT 1A | 5-HT | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Schizophrenia - chemically induced | Cognition Disorders - physiopathology | Cognition Disorders - chemically induced | Humans | Excitatory Amino Acid Antagonists - toxicity | Receptors, Serotonin - drug effects | Motor Activity - drug effects | Rats | Cognition Disorders - drug therapy | Receptors, Serotonin - metabolism | Animals | Schizophrenia - physiopathology | Serotonin - metabolism | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Disease Models, Animal | Cognition & reasoning | Psychopharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights